Trial
NCT02628769
A Study to Evaluate the Anti-inflammatory Effects of Solithromycin in Chronic Obstructive Pulmonary Disease
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Imperial College London
Collaborators
Melinta Therapeutics, Inc.
Condition
Pulmonary Disease, Chronic Obstructive
Intervention
Solithromycin
Why stopped
—
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-12-30